747 related articles for article (PubMed ID: 27121306)
1. TriGuard
Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
[TBL] [Abstract][Full Text] [Related]
2. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.
Baumbach A; Mullen M; Brickman AM; Aggarwal SK; Pietras CG; Forrest JK; Hildick-Smith D; Meller SM; Gambone L; den Heijer P; Margolis P; Voros S; Lansky AJ
EuroIntervention; 2015 May; 11(1):75-84. PubMed ID: 25868876
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
[TBL] [Abstract][Full Text] [Related]
4. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.
Samim M; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Kluin J; Ramjankhan F; Doevendans PA; Stella PR
J Thorac Cardiovasc Surg; 2015 Mar; 149(3):799-805.e1-2. PubMed ID: 25455466
[TBL] [Abstract][Full Text] [Related]
5. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
[TBL] [Abstract][Full Text] [Related]
6. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.
Naber CK; Ghanem A; Abizaid AA; Wolf A; Sinning JM; Werner N; Nickenig G; Schmitz T; Grube E
EuroIntervention; 2012 May; 8(1):43-50. PubMed ID: 22403768
[TBL] [Abstract][Full Text] [Related]
7. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.
Onsea K; Agostoni P; Samim M; Voskuil M; Kluin J; Budde R; Hendrikse J; Ramjankhan F; van Klarenbosch J; Doesburg P; Sieswerda G; Stella P
EuroIntervention; 2012 May; 8(1):51-6. PubMed ID: 22580248
[TBL] [Abstract][Full Text] [Related]
8. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
[TBL] [Abstract][Full Text] [Related]
9. An embolic deflection device for aortic valve interventions.
Nietlispach F; Wijesinghe N; Gurvitch R; Tay E; Carpenter JP; Burns C; Wood DA; Webb JG
JACC Cardiovasc Interv; 2010 Nov; 3(11):1133-8. PubMed ID: 21087748
[TBL] [Abstract][Full Text] [Related]
10. Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.
Mylotte D; Sudre A; Teiger E; Obadia JF; Lee M; Spence M; Khamis H; Al Nooryani A; Delhaye C; Amr G; Koussa M; Debry N; Piazza N; Modine T
JACC Cardiovasc Interv; 2016 Mar; 9(5):472-80. PubMed ID: 26965937
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
12. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
[TBL] [Abstract][Full Text] [Related]
13. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
14. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study.
Barbanti M; Sgroi C; Immè S; Aruta P; Deste W; Gulino S; Cannata S; Giarratana A; Bottari V; Giannazzo D; Garretto V; Patanè M; Benvenuto E; Capodanno D; Tamburino C
EuroIntervention; 2014 Jun; 10(2):241-7. PubMed ID: 24334876
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
[TBL] [Abstract][Full Text] [Related]
18. Initial findings using the V8 hourglass-shaped valvuloplasty balloon for postdilatation in treating paravalvular leaks associated with transcatheter self-expanding aortic valve prosthesis.
Latib A; Pedersen W; Maisano F; Lesser J; Ruparelia N; Figini F; Colombo A; Poulose A; Kolbeck J; Mooney M; Schwartz R; Youssef A; Ungs D; Goldenberg I; Sorajja P
Catheter Cardiovasc Interv; 2016 Jun; 87(7):1306-13. PubMed ID: 26945697
[TBL] [Abstract][Full Text] [Related]
19. A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
Lansky AJ; Makkar R; Nazif T; Messé S; Forrest J; Sharma R; Schofer J; Linke A; Brown D; Dhoble A; Horwitz P; Zang M; DeMarco F; Rajagopal V; Dwyer MG; Zivadinov R; Stella P; Rovin J; Parise H; Kodali S; Baumbach A; Moses J
Eur Heart J; 2021 Jul; 42(27):2670-2679. PubMed ID: 34000004
[TBL] [Abstract][Full Text] [Related]
20. Cerebral events and protection during transcatheter aortic valve replacement.
Freeman M; Barbanti M; Wood DA; Ye J; Webb JG
Catheter Cardiovasc Interv; 2014 Nov; 84(6):885-96. PubMed ID: 24550141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
